Photo of Janet C. Ruzich, DO
4.8
183 Ratings

Janet C. Ruzich, DO

Accepting New Patients
Offers Video Visits
1500 Division Street, Suite 220
Oregon City, OR 97045
2026.0 miles away
Medical Groups & Affiliations
Providence Medical Group - Oregon
Speaks: English
map

Providence Cancer Institute - Willamette Falls

1500 Division Street, Suite 220, Oregon City, OR 97045

Are you covered?

Check to see if your insurance is covered by this provider.

About Janet C. Ruzich

"At Providence Oncology and Hematology Care, we treat the whole person by balancing aggressive cancer therapy with comprehensive supportive care. Research has shown that there are simple things we can do to make treatment easier for patients and to speed recovery." With a special interest in breast cancer, lymphomas and other hematologic malignancies, Dr. Janet Ruzich has served patients and families in Portland since 2001 and Milwaukie since 2003. She currently sees patients in Oregon City.

After graduating from the Chicago College of Osteopathic Medicine, Dr. Ruzich completed her residency in internal medicine and her hematology/oncology fellowship training at Loyola University Medical Center in Maywood, Illinois. She is board-certified in internal medicine and medical oncology. Dr. Ruzich is associated with Providence Cancer Institute.

Fellowship

Loyola University Medical Center School of Nursing
2001

Internship

Presbyterian-St. Luke's Medical Center

Medical School

Midwestern University Chicago College of Osteopathic Medicine
1994

Residency

Loyola University Chicago Marcella Niehoff School of Nursing
1998

Residency

St. Joseph Hospital
1996

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute - Willamette Falls
1500 Division Street, Suite 220
Oregon City, OR 97045

Medical Groups & Affiliations
Providence Medical Group - Oregon

Affiliated Locations
Providence Willamette Falls Medical Center
Providence Milwaukie Hospital
Providence Portland Medical Center
Providence Hood River Memorial Hospital

Clinical Interests

  • Aids Related Malignancies
  • Anal Cancer
  • Anaplastic Meningioma
  • Anorectal Cancer
  • Anorectal Cancer Chemotherapy
  • Atypical Ductal Hyperplasia
  • Atypical Meningioma
  • Bladder Cancer
  • Bladder Cancer Genomics
  • Bone Cancer
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Breast Lump
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Cervical Cancer Genomics
  • Chemoradiation
  • Chest Wall Tumors
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer
  • Colon Cancer Genomics
  • Colorectal Cancer
  • Colorectal Cancer Chemotherapy
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Esophageal Cancer
  • Esophageal Cancer Chemotherapy
  • Fibrous Meningioma
  • Gallbladder Cancer Genomics
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Genomics
  • Hematologic Malignancies
  • Hemochromatosis
  • Histiocytic Sarcoma
  • Hypopharyngeal Cancer
  • Immature Teratoma
  • Laryngeal Cancer
  • Leukemia Genomics
  • Leukocytosis
  • Leukopenia
  • Liver Cancer Genomics
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Cancer Genomics
  • Lung Mass
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Lymphoma Genomics
  • Male Breast Cancer
  • Malignant Neoplasm Of Esophagus
  • Mediastinal Mass
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Mesothelioma
  • Metastatic Breast Cancer
  • Metastatic Liver Cancer
  • Metastatic Tumors To The Lungs
  • Mucosal Melanoma
  • Multiple Myeloma
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Neoplasm Of Salivary Gland
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oral Complications Of Cancer
  • Oral Lesions
  • Ovarian Cancer
  • Pancreas Cancer
  • Pancreatic Cancer Genomics
  • Plasma Cell Dyscrasia
  • Polycythemia
  • Primary Myelofibrosis
  • Prostate Cancer
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rectal Cancer Genomics
  • Recurrent Colorectal Cancer
  • Renal Cancer Genomics
  • Retroperitoneal Mass
  • Sarcoma Genomics
  • Sickle Cell Disease
  • Side Effects Of Cancer Treatment
  • Skeletal Metastasis
  • Skin Cancer Genomics
  • Small Cell Lung Cancer
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Stomach Cancer Chemotherapy
  • Stomach Cancer Genomics
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Thoracic Cancer
  • Thoracic Malignancy
  • Thrombocytopenia
  • Thyroid Cancer Genomics
  • Tracheal Cancer
  • Tracheal Mass
  • Unknown Primary Cancer
  • Vaginal Melanoma
  • Virtual Care
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web